Is STAB or MO a better dividend investment in 2026?

STAB currently yields 500000.00% with a 5% 5-year dividend growth rate. MO yields 6.27% with 4.3% growth. The better choice depends on your goal: STAB offers higher current income.

What is the dividend yield difference between STAB and MO?

STAB has a forward dividend yield of 500000.00% ($2.00/share annually). MO yields 6.27% ($4.20/share annually). The yield gap is 499993.73 percentage points.

Home › Compare › STAB vs MO

STAB vs MO: Dividend Comparison 2026

STAB yields 500000.00% · MO yields 6.27%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 STAB wins by $4.663521010693878e+33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

STAB

● Live price

500000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.663521010693878e+33M

Annual income

$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00

Full STAB calculator →

Altria Group Inc.

● Live price

6.27%

Share price

$67.02

Annual div

$4.20

5Y div CAGR

22.6%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$77.7K

Annual income

$28,968.54

Full MO calculator →

Portfolio growth — STAB vs MO

📍 STAB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	STAB	MO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, STAB + MO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

STAB pays

MO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STAB

Annual income on $10K today (after 15% tax)

$42,500,000.00/yr

After 10yr DRIP, annual income (after tax)

$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr

Annual income on $10K today (after 15% tax)

$532.68/yr

After 10yr DRIP, annual income (after tax)

$24,623.26/yr

At 15% tax rate, STAB beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STAB + MO for your $10,000?

STAB: 50%MO: 50%

100% MO50/50100% STAB

Portfolio after 10yr

$2.331760505346939e+33M

Annual income

$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.96%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

STAB

No analyst data

Altman Z

-22.8

Piotroski

4/9

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$61.25

-8.6% upside vs current

Range: $47.00 — $68.00

Altman Z

3.2

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STAB buys

MO buys

Politician	Chamber	Ticker	Type	Amount	Date
Ro Khanna	🏢 House	$MO	▲ Buy	$1,000 - $15,000	2025-08-04
Sheri Biggs	🏢 House	$MO	▼ Sell	$1,001 - $15,000	2025-03-19
Pete Sessions	🏢 House	$MO	▼ Sell	$1,001 - $15,000	2024-09-10
Ro Khanna	🏢 House	$MO	▲ Buy	$1,001 - $15,000	2024-03-20
Ro Khanna	🏢 House	$MO	▲ Buy	$1,001 - $15,000	2024-02-13
Virginia Foxx	🏢 House	$MO	▼ Sell	$1,001 - $15,000	2024-01-16
Virginia Foxx	🏢 House	$MO	▲ Buy	$1,001 - $15,000	2024-01-11
Ro Khanna	🏢 House	$MO	▼ Sell	$1,001 - $15,000	2024-01-10
Ro Khanna	🏢 House	$MO	▲ Buy	$1,001 - $15,000	2024-01-10
Virginia Foxx	🏢 House	$MO	▼ Sell	$15,001 - $50,000	2024-01-10

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSTABMO

Forward yield	500000.00% ✓	6.27%
Annual dividend / share	$2.00	$4.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	22.6% ✓
Portfolio after 10y	$4.663521010693878e+33M	$77.7K ✓
Annual income after 10y	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓	$28,968.54
Total dividends collected	$4.6634009849658873e+33M	$72.0K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: STAB vs MO ($10,000, DRIP)

Year	STAB Portfolio	STAB Income/yr	MO Portfolio	MO Income/yr	Gap
1← crossover	$50,010,700	$50,000,000.00	$10,558	$768.31	+$50.00M → STAB
2	$233,748,371,262	$233,694,859,813.08	$11,352	$1,015.87	+$233748.36M → STAB
3	$1,021,074,511,412,696	$1,020,824,400,655,446.10	$12,482	$1,367.86	+$1021074511.40M → STAB
4	$4,168,597,328,794,951,700	$4,167,504,779,067,739,000.00	$14,103	$1,883.39	+$4168597328794.94M → STAB
5	$15,905,475,114,600,665,000,000	$15,901,014,715,458,854,000,000.00	$16,472	$2,664.91	+$15905475114600664.00M → STAB
6	$56,718,938,532,531,060,000,000,000	$56,701,919,674,158,435,000,000,000.00	$20,024	$3,897.79	+$56718938532531060736.00M → STAB
7	$189,031,807,435,623,860,000,000,000,000	$188,971,118,171,394,040,000,000,000,000.00	$25,537	$5,933.74	+$1.8903180743562385e+23M → STAB
8	$588,799,810,476,518,260,000,000,000,000,000	$588,597,546,442,562,100,000,000,000,000,000.00	$34,478	$9,476.77	+$5.8879981047651824e+26M → STAB
9	$1,714,064,268,114,722,600,000,000,000,000,000,000	$1,713,434,252,317,512,700,000,000,000,000,000,000.00	$49,776	$16,022.63	+$1.7140642681147225e+30M → STAB
10	$4,663,521,010,693,878,300,000,000,000,000,000,000,000	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00	$77,699	$28,968.54	+$4.663521010693878e+33M → STAB

STAB vs MO: Complete Analysis 2026

STAB — Stock

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as expanding into fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. The company is based in Fort Collins, Colorado.

Full STAB Calculator →

MO — Consumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →

📬

Get this STAB vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STAB vs SCHD STAB vs JEPI STAB vs O STAB vs KO STAB vs MAIN STAB vs PM STAB vs BTI STAB vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.